DALLAS, TX--(Marketwired - Nov 28, 2017) - Capital Southwest Corporation ("Capital Southwest") (NASDAQ: CSWC) announced today that it supported the recent majority investment in LGM Pharma, LLC. ("LGM") by New Harbor Capital ("New Harbor") with a first lien term loan, a revolving credit facility and an equity co-investment. Capital Southwest serves as the sole administrative agent and lender on the credit facility.